Frequencies for first 10,000 rows of indi_pt variable in indi2004q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 1 0.01 0.01 ABDOMINAL INFECTION | 3 0.03 0.04 ABDOMINAL INJURY | 1 0.01 0.05 ABDOMINAL PAIN | 9 0.09 0.14 ABDOMINAL PAIN LOWER | 1 0.01 0.15 ABDOMINAL PAIN UPPER | 5 0.05 0.20 ABNORMAL BEHAVIOUR | 4 0.04 0.24 ABORTION INDUCED | 15 0.15 0.39 ABORTION THREATENED | 3 0.03 0.42 ABSCESS | 2 0.02 0.44 ACARODERMATITIS | 1 0.01 0.45 ACCIDENTAL EXPOSURE | 1 0.01 0.46 ACNE | 24 0.24 0.70 ACNE CYSTIC | 2 0.02 0.72 ACQUIRED IMMUNODEFICIENCY SYNDROME | 11 0.11 0.83 ACTINIC KERATOSIS | 1 0.01 0.84 ACUTE CORONARY SYNDROME | 3 0.03 0.87 ACUTE LEUKAEMIA | 2 0.02 0.89 ACUTE LYMPHOCYTIC LEUKAEMIA | 24 0.24 1.13 ACUTE MYELOID LEUKAEMIA | 53 0.53 1.66 ACUTE MYOCARDIAL INFARCTION | 9 0.09 1.75 ACUTE PROMYELOCYTIC LEUKAEMIA | 7 0.07 1.82 ACUTE PSYCHOSIS | 2 0.02 1.84 ACUTE PULMONARY OEDEMA | 2 0.02 1.86 ACUTE SINUSITIS | 3 0.03 1.89 ACUTE TONSILLITIS | 2 0.02 1.91 ADENOCARCINOMA | 3 0.03 1.94 AFFECTIVE DISORDER | 2 0.02 1.96 AGE INDETERMINATE MYOCARDIAL INFARCTION | 3 0.03 1.99 AGGRESSION | 1 0.01 2.00 AGITATION | 13 0.13 2.13 AGRANULOCYTOSIS | 1 0.01 2.14 ALCOHOL DETOXIFICATION | 1 0.01 2.15 ALCOHOL REHABILITATION | 1 0.01 2.16 ALCOHOL WITHDRAWAL SYNDROME | 3 0.03 2.19 ALCOHOLISM | 2 0.02 2.21 ALOPECIA | 5 0.05 2.26 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 2 0.02 2.28 AMNESIA | 2 0.02 2.30 AMYLOIDOSIS | 5 0.05 2.35 ANAEMIA | 14 0.14 2.49 ANAEMIA OF MALIGNANT DISEASE | 7 0.07 2.56 ANAEMIA POSTOPERATIVE | 1 0.01 2.57 ANAESTHESIA | 23 0.23 2.80 ANAL ABSCESS | 3 0.03 2.83 ANAL CANCER | 5 0.05 2.88 ANAL FISTULA | 1 0.01 2.89 ANALGESIC EFFECT | 4 0.04 2.93 ANALGESIC THERAPY | 1 0.01 2.94 ANAPHYLACTIC REACTION | 1 0.01 2.95 ANAPLASTIC ASTROCYTOMA | 4 0.04 2.99 ANGER | 3 0.03 3.02 ANGINA PECTORIS | 35 0.35 3.37 ANGINA UNSTABLE | 4 0.04 3.41 ANGIOGRAM | 2 0.02 3.43 ANGIOGRAM PULMONARY | 1 0.01 3.44 ANGIOGRAM RETINA | 1 0.01 3.45 ANGIOPATHY | 2 0.02 3.47 ANGIOPLASTY | 4 0.04 3.51 ANGIOSARCOMA | 1 0.01 3.52 ANKYLOSING SPONDYLITIS | 30 0.30 3.82 ANOREXIA | 3 0.03 3.85 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 1 0.01 3.86 ANTICOAGULANT THERAPY | 4 0.04 3.90 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.91 ANTIFUNGAL PROPHYLAXIS | 3 0.03 3.94 ANTIINFLAMMATORY THERAPY | 2 0.02 3.96 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 3.97 ANTIPHOSPHOLIPID SYNDROME | 3 0.03 4.00 ANTIPYRESIS | 3 0.03 4.03 ANTITHROMBIN III DEFICIENCY | 1 0.01 4.04 ANTIVIRAL PROPHYLAXIS | 10 0.10 4.14 ANXIETY | 69 0.69 4.83 ANXIETY DISORDER | 12 0.12 4.95 AORTIC VALVE REPLACEMENT | 4 0.04 4.99 AORTOGRAM | 1 0.01 5.00 APHTHOUS STOMATITIS | 1 0.01 5.01 APLASIA PURE RED CELL | 6 0.06 5.07 APLASTIC ANAEMIA | 1 0.01 5.08 APPENDICEAL ABSCESS | 1 0.01 5.09 APPENDICECTOMY | 1 0.01 5.10 APTYALISM | 1 0.01 5.11 ARRHYTHMIA | 20 0.20 5.31 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 5.32 ARTERIAL INJURY | 1 0.01 5.33 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.34 ARTERIAL STENOSIS | 2 0.02 5.36 ARTERIOGRAM | 2 0.02 5.38 ARTERIOGRAM CORONARY | 4 0.04 5.42 ARTERIOSCLEROSIS | 1 0.01 5.43 ARTHRALGIA | 42 0.42 5.85 ARTHRITIS | 33 0.33 6.18 ARTHRITIS BACTERIAL | 1 0.01 6.19 ARTHROPATHY | 3 0.03 6.22 ARTIFICIAL MENOPAUSE | 1 0.01 6.23 ASCARIASIS | 1 0.01 6.24 ASCITES | 2 0.02 6.26 ASPERGER'S DISORDER | 2 0.02 6.28 ASPERGILLOSIS | 6 0.06 6.34 ASTHENIA | 1 0.01 6.35 ASTHMA | 91 0.91 7.26 ASTROCYTOMA | 1 0.01 7.27 ATAXIA | 1 0.01 7.28 ATHEROSCLEROSIS OBLITERANS | 2 0.02 7.30 ATRIAL FIBRILLATION | 100 1.00 8.30 ATRIAL FLUTTER | 4 0.04 8.34 ATRIOVENTRICULAR BLOCK | 1 0.01 8.35 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 39 0.39 8.74 AUTOIMMUNE THYROIDITIS | 1 0.01 8.75 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 9 0.09 8.84 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 8.85 B PRECURSOR TYPE ACUTE LEUKAEMIA | 9 0.09 8.94 B-CELL LYMPHOMA | 1 0.01 8.95 BACK INJURY | 2 0.02 8.97 BACK PAIN | 62 0.62 9.59 BACTERAEMIA | 2 0.02 9.61 BACTERIAL INFECTION | 2 0.02 9.63 BACTERIURIA | 1 0.01 9.64 BARRETT'S OESOPHAGUS | 2 0.02 9.66 BEHCET'S SYNDROME | 2 0.02 9.68 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 9.69 BENIGN PROSTATIC HYPERPLASIA | 25 0.25 9.94 BILE DUCT CANCER | 2 0.02 9.96 BIPOLAR DISORDER | 50 0.50 10.46 BIPOLAR I DISORDER | 10 0.10 10.56 BLADDER CANCER | 24 0.24 10.80 BLADDER CANCER STAGE IV | 2 0.02 10.82 BLADDER STENOSIS | 1 0.01 10.83 BLADDER TUMOUR RESECTION | 1 0.01 10.84 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 10.85 BLASTOMYCOSIS | 1 0.01 10.86 BLEPHAROSPASM | 1 0.01 10.87 BLOOD CHOLESTEROL | 9 0.09 10.96 BLOOD CHOLESTEROL INCREASED | 48 0.48 11.44 BLOOD GLUCOSE | 3 0.03 11.47 BLOOD GLUCOSE ABNORMAL | 2 0.02 11.49 BLOOD GLUCOSE INCREASED | 1 0.01 11.50 BLOOD GROWTH HORMONE | 1 0.01 11.51 BLOOD POTASSIUM DECREASED | 1 0.01 11.52 BLOOD PRESSURE | 5 0.05 11.57 BLOOD PRESSURE INCREASED | 1 0.01 11.58 BLOOD PROLACTIN INCREASED | 1 0.01 11.59 BLOOD TRIGLYCERIDES INCREASED | 6 0.06 11.65 BLOOD URIC ACID INCREASED | 1 0.01 11.66 BODY HEIGHT BELOW NORMAL | 1 0.01 11.67 BODY TEMPERATURE INCREASED | 1 0.01 11.68 BODY TINEA | 1 0.01 11.69 BONE DISORDER | 3 0.03 11.72 BONE MARROW DISORDER | 1 0.01 11.73 BONE MARROW TRANSPLANT | 6 0.06 11.79 BONE NEOPLASM MALIGNANT | 2 0.02 11.81 BONE PAIN | 3 0.03 11.84 BONE SARCOMA | 1 0.01 11.85 BONE TUBERCULOSIS | 2 0.02 11.87 BORDERLINE PERSONALITY DISORDER | 4 0.04 11.91 BORRELIA INFECTION | 1 0.01 11.92 BRAIN NEOPLASM MALIGNANT | 3 0.03 11.95 BREAST CANCER | 134 1.34 13.29 BREAST CANCER FEMALE | 14 0.14 13.43 BREAST CANCER MALE | 1 0.01 13.44 BREAST CANCER METASTATIC | 40 0.40 13.84 BREAST CANCER STAGE I | 1 0.01 13.85 BREAST CANCER STAGE IV | 3 0.03 13.88 BREAST OPERATION | 1 0.01 13.89 BRONCHIAL CARCINOMA | 12 0.12 14.01 BRONCHITIS | 24 0.24 14.25 BRONCHITIS ACUTE | 1 0.01 14.26 BRONCHITIS CHRONIC | 5 0.05 14.31 BRONCHOPNEUMONIA | 2 0.02 14.33 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 14.36 BRONCHOSPASM | 1 0.01 14.37 BURSITIS | 2 0.02 14.39 CACHEXIA | 1 0.01 14.40 CAESAREAN SECTION | 1 0.01 14.41 CANCER PAIN | 78 0.78 15.19 CANDIDIASIS | 3 0.03 15.22 CARCINOID TUMOUR OF THE GASTROINTESTI.. | 1 0.01 15.23 CARCINOMA | 25 0.25 15.48 CARDIAC ASSISTANCE DEVICE USER | 1 0.01 15.49 CARDIAC ASTHMA | 1 0.01 15.50 CARDIAC DISORDER | 7 0.07 15.57 CARDIAC FAILURE | 13 0.13 15.70 CARDIAC FAILURE CHRONIC | 1 0.01 15.71 CARDIAC FAILURE CONGESTIVE | 37 0.37 16.08 CARDIAC IMAGING PROCEDURE | 1 0.01 16.09 CARDIAC MURMUR | 1 0.01 16.10 CARDIAC SARCOIDOSIS | 1 0.01 16.11 CARDIAC STRESS TEST | 7 0.07 16.18 CARDIAC VALVE DISEASE | 2 0.02 16.20 CARDIOMYOPATHY | 9 0.09 16.29 CARDIOVASCULAR DISORDER | 13 0.13 16.42 CARPAL TUNNEL SYNDROME | 2 0.02 16.44 CATABOLIC STATE | 1 0.01 16.45 CATAPLEXY | 1 0.01 16.46 CATARACT OPERATION | 2 0.02 16.48 CATHETER RELATED COMPLICATION | 1 0.01 16.49 CELLULITIS | 9 0.09 16.58 CENTRAL NERVOUS SYSTEM LYMPHOMA | 2 0.02 16.60 CENTRAL VENOUS CATHETERISATION | 1 0.01 16.61 CEREBRAL CIRCULATORY FAILURE | 1 0.01 16.62 CEREBRAL INFARCTION | 13 0.13 16.75 CEREBROVASCULAR ACCIDENT | 11 0.11 16.86 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 24 0.24 17.10 CEREBROVASCULAR DISORDER | 1 0.01 17.11 CEREBROVASCULAR INSUFFICIENCY | 2 0.02 17.13 CERVICAL RIB | 1 0.01 17.14 CERVICOBRACHIAL SYNDROME | 1 0.01 17.15 CERVIX CARCINOMA | 4 0.04 17.19 CERVIX CARCINOMA RECURRENT | 2 0.02 17.21 CHEMOTHERAPY | 62 0.62 17.83 CHEST PAIN | 6 0.06 17.89 CHLAMYDIAL INFECTION | 1 0.01 17.90 CHONDRODYSTROPHY | 1 0.01 17.91 CHRONIC FATIGUE SYNDROME | 2 0.02 17.93 CHRONIC HEPATITIS | 2 0.02 17.95 CHRONIC LYMPHOCYTIC LEUKAEMIA | 20 0.20 18.15 CHRONIC MYELOID LEUKAEMIA | 24 0.24 18.39 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 33 0.33 18.72 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 2 0.02 18.74 CLEAR CELL CARCINOMA OF THE KIDNEY | 1 0.01 18.75 CLOSTRIDIUM COLITIS | 2 0.02 18.77 CLUSTER HEADACHE | 9 0.09 18.86 COCCIDIOIDOMYCOSIS | 1 0.01 18.87 COELIAC DISEASE | 1 0.01 18.88 COGNITIVE DISORDER | 1 0.01 18.89 COLECTOMY PARTIAL | 1 0.01 18.90 COLITIS | 2 0.02 18.92 COLITIS ULCERATIVE | 14 0.14 19.06 COLON CANCER | 19 0.19 19.25 COLON CANCER METASTATIC | 5 0.05 19.30 COLONOSCOPY | 2 0.02 19.32 COLORECTAL CANCER | 14 0.14 19.46 COLORECTAL CANCER METASTATIC | 25 0.25 19.71 COLORECTAL CANCER STAGE IV | 1 0.01 19.72 COMPLEX PARTIAL SEIZURES | 6 0.06 19.78 COMPRESSION FRACTURE | 1 0.01 19.79 COMPUTERISED TOMOGRAM | 10 0.10 19.89 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 19.90 CONDITION AGGRAVATED | 1 0.01 19.91 CONFUSIONAL STATE | 1 0.01 19.92 CONGESTIVE CARDIOMYOPATHY | 1 0.01 19.93 CONJUNCTIVITIS | 1 0.01 19.94 CONJUNCTIVITIS BACTERIAL | 2 0.02 19.96 CONSTIPATION | 25 0.25 20.21 CONTRACEPTION | 41 0.41 20.62 CONTUSION | 2 0.02 20.64 CONVULSION | 66 0.66 21.30 CONVULSION PROPHYLAXIS | 3 0.03 21.33 CORD BLOOD TRANSPLANT THERAPY | 1 0.01 21.34 CORNEAL GRAFT REJECTION | 2 0.02 21.36 CORNEAL TRANSPLANT | 1 0.01 21.37 CORNEAL ULCER | 1 0.01 21.38 CORONARY ANGIOPLASTY | 6 0.06 21.44 CORONARY ARTERIAL STENT INSERTION | 1 0.01 21.45 CORONARY ARTERY ATHEROSCLEROSIS | 1 0.01 21.46 CORONARY ARTERY DISEASE | 30 0.30 21.76 CORONARY ARTERY INSUFFICIENCY | 1 0.01 21.77 CORONARY ARTERY SURGERY | 3 0.03 21.80 COSTOCHONDRITIS | 1 0.01 21.81 COUGH | 14 0.14 21.95 CROHN'S DISEASE | 77 0.77 22.72 CRYOGLOBULINAEMIA | 1 0.01 22.73 CRYPTOGENIC ORGANIZING PNEUMONIA | 1 0.01 22.74 CYSTIC FIBROSIS | 2 0.02 22.76 CYSTITIS | 8 0.08 22.84 CYSTITIS INTERSTITIAL | 2 0.02 22.86 CYTOMEGALOVIRUS INFECTION | 2 0.02 22.88 DECUBITUS ULCER | 1 0.01 22.89 DEEP VEIN THROMBOSIS | 17 0.17 23.06 DEEP VENOUS THROMBOSIS PROPHYLAXIS | 4 0.04 23.10 DELIRIUM | 2 0.02 23.12 DELUSION | 4 0.04 23.16 DEMENTIA | 16 0.16 23.32 DEMENTIA ALZHEIMER'S TYPE | 29 0.29 23.61 DEMYELINATING POLYNEUROPATHY | 1 0.01 23.62 DENTAL CARIES | 1 0.01 23.63 DENTAL DISCOMFORT | 1 0.01 23.64 DEPRESSION | 343 3.43 27.07 DEPRESSIVE SYMPTOM | 1 0.01 27.08 DERMATITIS | 1 0.01 27.09 DERMATITIS ATOPIC | 4 0.04 27.13 DERMATITIS CONTACT | 1 0.01 27.14 DERMATOMYOSITIS | 1 0.01 27.15 DERMATOSIS | 1 0.01 27.16 DIABETES MELLITUS | 183 1.83 28.99 DIABETES MELLITUS INSULIN-DEPENDENT | 37 0.37 29.36 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 112 1.12 30.48 DIABETIC GASTROPARESIS | 2 0.02 30.50 DIABETIC NEUROPATHY | 6 0.06 30.56 DIAGNOSTIC PROCEDURE | 1 0.01 30.57 DIALYSIS | 2 0.02 30.59 DIAPHRAGMATIC HERNIA | 2 0.02 30.61 DIARRHOEA | 8 0.08 30.69 DIARRHOEA INFECTIOUS | 1 0.01 30.70 DIFFUSE LARGE B-CELL LYMPHOMA | 9 0.09 30.79 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III | 1 0.01 30.80 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV | 1 0.01 30.81 DISEASE RECURRENCE | 1 0.01 30.82 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 30.85 DISSEMINATED TUBERCULOSIS | 2 0.02 30.87 DISTURBANCE IN ATTENTION | 1 0.01 30.88 DIURETIC THERAPY | 1 0.01 30.89 DIVERTICULITIS | 1 0.01 30.90 DIVERTICULUM | 2 0.02 30.92 DIZZINESS | 3 0.03 30.95 DRUG ABUSER | 11 0.11 31.06 DRUG DEPENDENCE | 3 0.03 31.09 DRUG EXPOSURE DURING PREGNANCY | 2 0.02 31.11 DRUG HYPERSENSITIVITY | 1 0.01 31.12 DRUG LEVEL | 1 0.01 31.13 DRUG USE FOR UNKNOWN INDICATION | 313 3.13 34.26 DRUG WITHDRAWAL SYNDROME | 5 0.05 34.31 DRY MOUTH | 2 0.02 34.33 DUODENAL ULCER | 2 0.02 34.35 DYSLIPIDAEMIA | 16 0.16 34.51 DYSMENORRHOEA | 2 0.02 34.53 DYSPEPSIA | 22 0.22 34.75 DYSPHAGIA | 2 0.02 34.77 DYSPHONIA | 1 0.01 34.78 DYSPNOEA | 2 0.02 34.80 DYSTHYMIC DISORDER | 4 0.04 34.84 DYSTONIA | 1 0.01 34.85 DYSURIA | 3 0.03 34.88 EAR DISORDER | 1 0.01 34.89 EAR INFECTION | 3 0.03 34.92 EAR PAIN | 1 0.01 34.93 EATING DISORDER | 4 0.04 34.97 ECTOPIC PREGNANCY | 2 0.02 34.99 ECZEMA | 3 0.03 35.02 EMBOLISM | 1 0.01 35.03 EMPHYSEMA | 2 0.02 35.05 ENCEPHALITIS | 1 0.01 35.06 ENCEPHALITIS VIRAL | 2 0.02 35.08 ENDOCARDITIS | 1 0.01 35.09 ENDOCARDITIS CANDIDA | 1 0.01 35.10 ENDOCARDITIS ENTEROCOCCAL | 1 0.01 35.11 ENDODONTIC PROCEDURE | 3 0.03 35.14 ENDOMETRIAL CANCER | 2 0.02 35.16 ENDOMETRIOMA | 1 0.01 35.17 ENDOMETRIOSIS | 3 0.03 35.20 ENDOPHTHALMITIS | 1 0.01 35.21 ENDOSCOPIC RETROGRADE CHOLANGIOPANCRE.. | 1 0.01 35.22 ENTERITIS | 3 0.03 35.25 ENTEROCOLITIS INFECTIOUS | 2 0.02 35.27 ENZYME INHIBITION | 1 0.01 35.28 EPICONDYLITIS | 1 0.01 35.29 EPIDIDYMITIS | 1 0.01 35.30 EPIDURAL ANAESTHESIA | 4 0.04 35.34 EPILEPSY | 68 0.68 36.02 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 36.03 ERECTILE DYSFUNCTION | 27 0.27 36.30 ERYSIPELAS | 3 0.03 36.33 ERYTHEMA MULTIFORME | 2 0.02 36.35 ESCHAR | 1 0.01 36.36 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 36.37 ESSENTIAL HYPERTENSION | 26 0.26 36.63 ESSENTIAL THROMBOCYTHAEMIA | 2 0.02 36.65 ESSENTIAL TREMOR | 1 0.01 36.66 EX-SMOKER | 35 0.35 37.01 EXOSTOSIS | 1 0.01 37.02 EYE DISORDER | 1 0.01 37.03 EYE ROLLING | 1 0.01 37.04 FABRY'S DISEASE | 2 0.02 37.06 FACIAL PALSY | 1 0.01 37.07 FACTOR VIII DEFICIENCY | 5 0.05 37.12 FAILED TRIAL OF LABOUR | 1 0.01 37.13 FATIGUE | 3 0.03 37.16 FEBRILE NEUTROPENIA | 2 0.02 37.18 FIBROMYALGIA | 7 0.07 37.25 FILARIASIS | 1 0.01 37.26 FISTULA | 2 0.02 37.28 FLATULENCE | 3 0.03 37.31 FLEA INFESTATION | 1 0.01 37.32 FLUID REPLACEMENT | 1 0.01 37.33 FLUID RETENTION | 1 0.01 37.34 FOLATE DEFICIENCY | 3 0.03 37.37 FOOD ALLERGY | 1 0.01 37.38 FUNGAEMIA | 1 0.01 37.39 FUNGAL INFECTION | 13 0.13 37.52 FUSOBACTERIUM INFECTION | 1 0.01 37.53 GASTRIC CANCER | 25 0.25 37.78 GASTRIC DISORDER | 2 0.02 37.80 GASTRIC POLYPS | 1 0.01 37.81 GASTRIC ULCER | 28 0.28 38.09 GASTRITIS | 21 0.21 38.30 GASTRITIS HAEMORRHAGIC | 1 0.01 38.31 GASTROENTERITIS | 1 0.01 38.32 GASTROINTESTINAL CANDIDIASIS | 1 0.01 38.33 GASTROINTESTINAL DISORDER | 4 0.04 38.37 GASTROINTESTINAL HAEMORRHAGE | 1 0.01 38.38 GASTROINTESTINAL STROMAL TUMOUR | 15 0.15 38.53 GASTROOESOPHAGEAL REFLUX DISEASE | 29 0.29 38.82 GAUCHER'S DISEASE | 12 0.12 38.94 GENERAL ANAESTHESIA | 5 0.05 38.99 GENERALISED ANXIETY DISORDER | 8 0.08 39.07 GERM CELL CANCER | 6 0.06 39.13 GESTATIONAL DIABETES | 4 0.04 39.17 GESTATIONAL TROPHOBLASTIC TUMOUR | 4 0.04 39.21 GLAUCOMA | 6 0.06 39.27 GLIOBLASTOMA | 8 0.08 39.35 GLIOBLASTOMA MULTIFORME | 4 0.04 39.39 GLYCOPEPTIDE ANTIBIOTIC RESISTANT ENT.. | 2 0.02 39.41 GOITRE | 4 0.04 39.45 GOUT | 13 0.13 39.58 GRAFT VERSUS HOST DISEASE | 4 0.04 39.62 GRAND MAL CONVULSION | 7 0.07 39.69 GROIN PAIN | 1 0.01 39.70 GROWTH HORMONE DEFICIENCY | 7 0.07 39.77 GROWTH RETARDATION | 1 0.01 39.78 HAEMATURIA | 1 0.01 39.79 HAEMODIALYSIS | 1 0.01 39.80 HAEMODIALYSIS-INDUCED SYMPTOM | 2 0.02 39.82 HAEMODILUTION | 1 0.01 39.83 HAEMOPHILIA | 14 0.14 39.97 HAEMOPHILIA A WITH ANTI FACTOR VIII | 1 0.01 39.98 HAEMORRHAGE | 9 0.09 40.07 HAEMOSIDEROSIS | 2 0.02 40.09 HAIRY CELL LEUKAEMIA | 2 0.02 40.11 HALLUCINATION | 4 0.04 40.15 HEADACHE | 15 0.15 40.30 HEART RATE | 1 0.01 40.31 HEART RATE INCREASED | 1 0.01 40.32 HEART RATE IRREGULAR | 2 0.02 40.34 HEART TRANSPLANT | 11 0.11 40.45 HEART VALVE REPLACEMENT | 2 0.02 40.47 HELICOBACTER INFECTION | 3 0.03 40.50 HEPARIN-INDUCED THROMBOCYTOPENIA | 3 0.03 40.53 HEPATIC CIRRHOSIS | 8 0.08 40.61 HEPATIC FAILURE | 1 0.01 40.62 HEPATIC FUNCTION ABNORMAL | 1 0.01 40.63 HEPATIC NEOPLASM MALIGNANT | 8 0.08 40.71 HEPATITIS | 5 0.05 40.76 HEPATITIS B | 18 0.18 40.94 HEPATITIS B VIRUS | 1 0.01 40.95 HEPATITIS C | 95 0.95 41.90 HEPATITIS C VIRUS | 3 0.03 41.93 HEPATITIS CHRONIC ACTIVE | 1 0.01 41.94 HEPATO-LENTICULAR DEGENERATION | 1 0.01 41.95 HEPATOSPLENIC CANDIDIASIS | 1 0.01 41.96 HERNIA | 2 0.02 41.98 HERNIA REPAIR | 1 0.01 41.99 HERPES SIMPLEX | 15 0.15 42.14 HERPES VIRUS INFECTION | 4 0.04 42.18 HERPES ZOSTER | 49 0.49 42.67 HIATUS HERNIA | 5 0.05 42.72 HICCUPS | 3 0.03 42.75 HIGH DENSITY LIPOPROTEIN | 1 0.01 42.76 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 42.78 HIP ARTHROPLASTY | 3 0.03 42.81 HIP SURGERY | 1 0.01 42.82 HISTOPLASMOSIS | 1 0.01 42.83 HIV INFECTION | 422 4.22 47.05 HIV INFECTION CDC GROUP IV SUBGROUP E | 3 0.03 47.08 HIV TEST POSITIVE | 1 0.01 47.09 HOARSENESS | 1 0.01 47.10 HODGKIN'S DISEASE | 21 0.21 47.31 HODGKIN'S DISEASE RECURRENT | 1 0.01 47.32 HORMONE REPLACEMENT THERAPY | 15 0.15 47.47 HOT FLUSH | 1 0.01 47.48 HUMORAL IMMUNE DEFECT | 1 0.01 47.49 HYPERCALCAEMIA | 1 0.01 47.50 HYPERCHOLESTEROLAEMIA | 94 0.94 48.44 HYPERGLYCAEMIA | 1 0.01 48.45 HYPERKALAEMIA | 3 0.03 48.48 HYPERLIPIDAEMIA | 63 0.63 49.11 HYPERPARATHYROIDISM | 1 0.01 49.12 HYPERPARATHYROIDISM SECONDARY | 2 0.02 49.14 HYPERPHOSPHATAEMIA | 23 0.23 49.37 HYPERPHOSPHATASAEMIA | 1 0.01 49.38 HYPERPYREXIA | 1 0.01 49.39 HYPERSENSITIVITY | 18 0.18 49.57 HYPERSOMNIA | 1 0.01 49.58 HYPERTENSION | 383 3.83 53.41 HYPERTHYROIDISM | 4 0.04 53.45 HYPERTONIC BLADDER | 3 0.03 53.48 HYPERTRIGLYCERIDAEMIA | 3 0.03 53.51 HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY | 2 0.02 53.53 HYPERURICAEMIA | 7 0.07 53.60 HYPOAESTHESIA | 1 0.01 53.61 HYPOALBUMINAEMIA | 1 0.01 53.62 HYPOCALCAEMIA | 1 0.01 53.63 HYPOGAMMAGLOBULINAEMIA | 2 0.02 53.65 HYPOGONADISM MALE | 1 0.01 53.66 HYPOKALAEMIA | 6 0.06 53.72 HYPOMANIA | 1 0.01 53.73 HYPOPARATHYROIDISM | 1 0.01 53.74 HYPOPHARYNGEAL CANCER | 4 0.04 53.78 HYPOPITUITARISM | 8 0.08 53.86 HYPOTENSION | 7 0.07 53.93 HYPOTHYROIDISM | 26 0.26 54.19 HYPOTONIA | 2 0.02 54.21 HYPOVITAMINOSIS | 1 0.01 54.22 HYPOVOLAEMIA | 1 0.01 54.23 HYSTEROSCOPY | 1 0.01 54.24 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 54.25 ILL-DEFINED DISORDER | 376 3.76 58.01 IMMUNISATION | 2 0.02 58.03 IMMUNODEFICIENCY | 2 0.02 58.05 IMMUNODEFICIENCY COMMON VARIABLE | 3 0.03 58.08 IMMUNOSUPPRESSANT DRUG THERAPY | 9 0.09 58.17 IMMUNOSUPPRESSION | 19 0.19 58.36 IMPAIRED GASTRIC EMPTYING | 9 0.09 58.45 IMPAIRED HEALING | 1 0.01 58.46 IMPATIENCE | 1 0.01 58.47 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 1 0.01 58.48 INCISION SITE COMPLICATION | 1 0.01 58.49 INCISIONAL HERNIA REPAIR | 1 0.01 58.50 INCONTINENCE | 3 0.03 58.53 INDUCED LABOUR | 3 0.03 58.56 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 2 0.02 58.58 INDUCTION OF ANAESTHESIA | 20 0.20 58.78 INFECTION | 25 0.25 59.03 INFECTION PROPHYLAXIS | 12 0.12 59.15 INFERTILITY FEMALE | 2 0.02 59.17 INFLAMMATION | 7 0.07 59.24 INFLAMMATORY BOWEL DISEASE | 1 0.01 59.25 INFLAMMATORY CARCINOMA OF THE BREAST | 6 0.06 59.31 INFLUENZA | 14 0.14 59.45 INFLUENZA IMMUNISATION | 2 0.02 59.47 INJURY | 1 0.01 59.48 INSOMNIA | 36 0.36 59.84 INSULIN RESISTANCE | 1 0.01 59.85 INSULIN-REQUIRING TYPE II DIABETES ME.. | 2 0.02 59.87 INTENTIONAL OVERDOSE | 2 0.02 59.89 INTERSTITIAL LUNG DISEASE | 7 0.07 59.96 INTERTRIGO | 1 0.01 59.97 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 59.98 INTERVERTEBRAL DISC DISORDER | 1 0.01 59.99 INTESTINAL HYPOMOTILITY | 1 0.01 60.00 INTRAOCULAR PRESSURE INCREASED | 4 0.04 60.04 INTUBATION | 1 0.01 60.05 IRON DEFICIENCY | 2 0.02 60.07 IRON DEFICIENCY ANAEMIA | 4 0.04 60.11 IRRITABILITY | 1 0.01 60.12 IRRITABLE BOWEL SYNDROME | 26 0.26 60.38 ISCHAEMIC STROKE | 1 0.01 60.39 JAW INFLAMMATION | 2 0.02 60.41 JOINT ARTHROPLASTY | 2 0.02 60.43 JOINT INJURY | 2 0.02 60.45 JOINT SWELLING | 1 0.01 60.46 JUVENILE ARTHRITIS | 6 0.06 60.52 KAPOSI'S SARCOMA | 1 0.01 60.53 KERATITIS | 1 0.01 60.54 KERATOCONJUNCTIVITIS SICCA | 1 0.01 60.55 KIDNEY INFECTION | 2 0.02 60.57 KNEE ARTHROPLASTY | 1 0.01 60.58 LABOUR INDUCTION | 1 0.01 60.59 LABYRINTHITIS | 1 0.01 60.60 LACRIMATION INCREASED | 2 0.02 60.62 LARGE INTESTINE CARCINOMA | 5 0.05 60.67 LARYNGEAL CANCER STAGE IV | 1 0.01 60.68 LARYNGOPHARYNGITIS | 1 0.01 60.69 LARYNGOTRACHEO BRONCHITIS | 1 0.01 60.70 LEIOMYOSARCOMA METASTATIC | 3 0.03 60.73 LENNOX-GASTAUT SYNDROME | 1 0.01 60.74 LEUKAEMIA | 4 0.04 60.78 LICE INFESTATION | 2 0.02 60.80 LIGAMENT INJURY | 1 0.01 60.81 LIMB INJURY | 1 0.01 60.82 LIPIDS | 1 0.01 60.83 LIPOSARCOMA | 1 0.01 60.84 LIPOSARCOMA METASTATIC | 1 0.01 60.85 LITHOTRIPSY | 1 0.01 60.86 LIVER ABSCESS | 1 0.01 60.87 LIVER TRANSPLANT | 14 0.14 61.01 LOCAL ANAESTHESIA | 18 0.18 61.19 LOCALISED INFECTION | 1 0.01 61.20 LOCALISED OSTEOARTHRITIS | 12 0.12 61.32 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 61.33 LOW DENSITY LIPOPROTEIN INCREASED | 3 0.03 61.36 LOWER RESPIRATORY TRACT INFECTION | 10 0.10 61.46 LUMBAR SPINAL STENOSIS | 1 0.01 61.47 LUNG ADENOCARCINOMA | 16 0.16 61.63 LUNG ADENOCARCINOMA STAGE III | 1 0.01 61.64 LUNG CANCER METASTATIC | 3 0.03 61.67 LUNG INFECTION | 7 0.07 61.74 LUNG INFECTION PSEUDOMONAL | 2 0.02 61.76 LUNG NEOPLASM MALIGNANT | 41 0.41 62.17 LUNG SQUAMOUS CELL CARCINOMA STAGE III | 1 0.01 62.18 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 3 0.03 62.21 LUNG TRANSPLANT | 2 0.02 62.23 LYME DISEASE | 1 0.01 62.24 LYMPHADENOPATHY | 1 0.01 62.25 LYMPHANGIOSIS CARCINOMATOSA | 2 0.02 62.27 LYMPHOMA | 21 0.21 62.48 MACULAR DEGENERATION | 2 0.02 62.50 MAJOR DEPRESSION | 15 0.15 62.65 MALARIA PROPHYLAXIS | 12 0.12 62.77 MALE PATTERN BALDNESS | 4 0.04 62.81 MALIGNANT ANORECTAL NEOPLASM | 1 0.01 62.82 MALIGNANT FIBROUS HISTIOCYTOMA | 1 0.01 62.83 MALIGNANT MELANOMA | 17 0.17 63.00 MALIGNANT NEOPLASM OF PLEURA | 1 0.01 63.01 MALIGNANT PALATE NEOPLASM | 3 0.03 63.04 MANIA | 3 0.03 63.07 MANTLE CELL LYMPHOMA | 2 0.02 63.09 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 63.10 MEDICATION ERROR | 7 0.07 63.17 MEDULLARY THYROID CANCER | 1 0.01 63.18 MENINGITIS | 4 0.04 63.22 MENINGITIS BACTERIAL | 1 0.01 63.23 MENINGITIS CRYPTOCOCCAL | 1 0.01 63.24 MENINGITIS TUBERCULOUS | 1 0.01 63.25 MENOPAUSAL SYMPTOMS | 3 0.03 63.28 MENOPAUSE | 5 0.05 63.33 MENORRHAGIA | 1 0.01 63.34 MENSTRUATION IRREGULAR | 2 0.02 63.36 MENTAL DISORDER | 2 0.02 63.38 MENTAL IMPAIRMENT | 1 0.01 63.39 MERALGIA PARAESTHETICA | 1 0.01 63.40 MESOTHELIOMA | 9 0.09 63.49 MESOTHELIOMA MALIGNANT | 3 0.03 63.52 METASTASES TO ADRENALS | 1 0.01 63.53 METASTASES TO BONE | 15 0.15 63.68 METASTASES TO CENTRAL NERVOUS SYSTEM | 8 0.08 63.76 METASTASES TO LIVER | 6 0.06 63.82 METASTASES TO LUNG | 3 0.03 63.85 METASTASIS | 2 0.02 63.87 METASTATIC CARCINOMA OF THE BLADDER | 1 0.01 63.88 METASTATIC MALIGNANT MELANOMA | 8 0.08 63.96 METASTATIC RENAL CELL CARCINOMA | 5 0.05 64.01 METRORRHAGIA | 1 0.01 64.02 MICTURITION URGENCY | 1 0.01 64.03 MIDDLE EAR EFFUSION | 1 0.01 64.04 MIGRAINE | 35 0.35 64.39 MIGRAINE PROPHYLAXIS | 3 0.03 64.42 MIGRAINE WITHOUT AURA | 1 0.01 64.43 MINERAL SUPPLEMENTATION | 1 0.01 64.44 MITRAL VALVE DISEASE | 2 0.02 64.46 MITRAL VALVE PROLAPSE | 2 0.02 64.48 MONARTHRITIS | 1 0.01 64.49 MOOD ALTERED | 1 0.01 64.50 MOOD SWINGS | 2 0.02 64.52 MUCOPOLYSACCHARIDOSIS IH | 1 0.01 64.53 MULTIPLE MYELOMA | 97 0.97 65.50 MULTIPLE SCLEROSIS | 289 2.89 68.39 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 68.40 MUSCLE CRAMP | 6 0.06 68.46 MUSCLE RELAXANT THERAPY | 1 0.01 68.47 MUSCLE SPASMS | 10 0.10 68.57 MUSCLE SPASTICITY | 14 0.14 68.71 MUSCLE STRAIN | 2 0.02 68.73 MUSCULOSKELETAL PAIN | 2 0.02 68.75 MYALGIA | 8 0.08 68.83 MYASTHENIA GRAVIS | 2 0.02 68.85 MYCOBACTERIAL INFECTION | 5 0.05 68.90 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 68.91 MYCOSIS FUNGOIDES | 1 0.01 68.92 MYELODYSPLASTIC SYNDROME | 16 0.16 69.08 MYELOFIBROSIS | 2 0.02 69.10 MYELOID LEUKAEMIA | 2 0.02 69.12 MYOCARDIAL INFARCTION | 43 0.43 69.55 MYOCARDIAL ISCHAEMIA | 6 0.06 69.61 MYOPATHY | 1 0.01 69.62 MYOSITIS | 1 0.01 69.63 NAIL TINEA | 19 0.19 69.82 NARCOLEPSY | 2 0.02 69.84 NASAL CONGESTION | 4 0.04 69.88 NASOPHARYNGITIS | 46 0.46 70.34 NAUSEA | 27 0.27 70.61 NECK PAIN | 5 0.05 70.66 NEOPLASM | 3 0.03 70.69 NEOPLASM MALIGNANT | 6 0.06 70.75 NEOPLASM RECURRENCE | 7 0.07 70.82 NEPHROBLASTOMA | 2 0.02 70.84 NEPHROGENIC ANAEMIA | 3 0.03 70.87 NEPHROTIC SYNDROME | 3 0.03 70.90 NERVOUS SYSTEM DISORDER | 1 0.01 70.91 NERVOUS SYSTEM NEOPLASM | 1 0.01 70.92 NERVOUSNESS | 2 0.02 70.94 NEURALGIA | 7 0.07 71.01 NEUROBLASTOMA | 3 0.03 71.04 NEUROPATHIC PAIN | 6 0.06 71.10 NEUROPATHY | 3 0.03 71.13 NEUROPATHY PERIPHERAL | 3 0.03 71.16 NEUROSIS | 1 0.01 71.17 NIGHT SWEATS | 1 0.01 71.18 NON-HODGKIN'S LYMPHOMA | 18 0.18 71.36 NON-SMALL CELL LUNG CANCER | 81 0.81 72.17 NON-SMALL CELL LUNG CANCER METASTATIC | 2 0.02 72.19 NON-SMALL CELL LUNG CANCER RECURRENT | 1 0.01 72.20 NON-SMALL CELL LUNG CANCER STAGE IIIA | 1 0.01 72.21 NON-SMALL CELL LUNG CANCER STAGE IIIB | 1 0.01 72.22 NON-SMALL CELL LUNG CANCER STAGE IV | 4 0.04 72.26 NOSOCOMIAL INFECTION | 2 0.02 72.28 NUCLEAR MAGNETIC RESONANCE IMAGING | 2 0.02 72.30 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 72.31 NUTRITIONAL SUPPORT | 2 0.02 72.33 OBESITY | 12 0.12 72.45 OBSESSIVE RUMINATION | 3 0.03 72.48 OBSESSIVE-COMPULSIVE DISORDER | 13 0.13 72.61 OEDEMA | 6 0.06 72.67 OEDEMA DUE TO CARDIAC DISEASE | 2 0.02 72.69 OEDEMA PERIPHERAL | 3 0.03 72.72 OESOPHAGEAL ADENOCARCINOMA | 3 0.03 72.75 OESOPHAGEAL CANDIDIASIS | 3 0.03 72.78 OESOPHAGEAL CARCINOMA | 36 0.36 73.14 OESOPHAGEAL DISORDER | 3 0.03 73.17 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 73.18 OESOPHAGITIS | 2 0.02 73.20 OESOPHAGOGASTRODUODENOSCOPY | 1 0.01 73.21 ONCHOCERCIASIS | 2 0.02 73.23 ONYCHOMYCOSIS | 8 0.08 73.31 ORAL CANDIDIASIS | 4 0.04 73.35 ORAL CONTRACEPTION | 8 0.08 73.43 ORCHITIS | 1 0.01 73.44 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 7 0.07 73.51 OSTEITIS | 3 0.03 73.54 OSTEOARTHRITIS | 33 0.33 73.87 OSTEOMYELITIS | 8 0.08 73.95 OSTEOMYELITIS ACUTE | 3 0.03 73.98 OSTEOPENIA | 5 0.05 74.03 OSTEOPOROSIS | 98 0.98 75.01 OSTEOPOROSIS POSTMENOPAUSAL | 5 0.05 75.06 OSTEOPOROSIS PROPHYLAXIS | 6 0.06 75.12 OSTEOPOROTIC FRACTURE | 1 0.01 75.13 OTITIS MEDIA | 2 0.02 75.15 OTITIS MEDIA ACUTE | 1 0.01 75.16 OVARIAN CANCER | 56 0.56 75.72 OVARIAN CYST | 2 0.02 75.74 OVERDOSE | 5 0.05 75.79 PAIN | 191 1.91 77.70 PAIN IN EXTREMITY | 15 0.15 77.85 PAIN MANAGEMENT | 3 0.03 77.88 PAIN PROPHYLAXIS | 1 0.01 77.89 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 77.90 PALPITATIONS | 1 0.01 77.91 PANCREATIC CARCINOMA | 21 0.21 78.12 PANCREATIC CARCINOMA METASTATIC | 4 0.04 78.16 PANCREATICODUODENECTOMY | 1 0.01 78.17 PANCYTOPENIA | 1 0.01 78.18 PANIC ATTACK | 2 0.02 78.20 PANIC DISORDER | 10 0.10 78.30 PARAESTHESIA | 1 0.01 78.31 PARANOIA | 1 0.01 78.32 PARATYPHOID FEVER | 2 0.02 78.34 PARENTERAL NUTRITION | 2 0.02 78.36 PARKINSON'S DISEASE | 34 0.34 78.70 PARKINSONISM | 4 0.04 78.74 PARTIAL SEIZURES | 4 0.04 78.78 PATENT DUCTUS ARTERIOSUS | 1 0.01 78.79 PELVIC INFLAMMATORY DISEASE | 1 0.01 78.80 PEPTIC ULCER | 2 0.02 78.82 PERICARDITIS RHEUMATIC | 1 0.01 78.83 PERINATAL BRAIN DAMAGE | 1 0.01 78.84 PERIODONTITIS | 1 0.01 78.85 PERIPHERAL VASCULAR DISORDER | 4 0.04 78.89 PERITONEAL DIALYSIS | 6 0.06 78.95 PERITONITIS | 2 0.02 78.97 PERSECUTORY DELUSION | 3 0.03 79.00 PERSONALITY DISORDER | 3 0.03 79.03 PETIT MAL EPILEPSY | 4 0.04 79.07 PHAEOCHROMOCYTOMA | 1 0.01 79.08 PHARYNGITIS | 14 0.14 79.22 PHARYNGOLARYNGEAL PAIN | 3 0.03 79.25 PHLEBOTHROMBOSIS | 1 0.01 79.26 PITUITARY TUMOUR | 1 0.01 79.27 PLANTAR FASCIITIS | 1 0.01 79.28 PLASMACYTOMA | 2 0.02 79.30 PLATELET ADHESIVENESS INCREASED | 1 0.01 79.31 PLATELET COUNT DECREASED | 2 0.02 79.33 PLEURAL EFFUSION | 1 0.01 79.34 PNEUMOCYSTIS CARINII INFECTION | 1 0.01 79.35 PNEUMOCYSTIS CARINII PNEUMONIA | 3 0.03 79.38 PNEUMONIA | 52 0.52 79.90 PNEUMONIA ASPIRATION | 2 0.02 79.92 PNEUMONIA BACTERIAL | 8 0.08 80.00 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 80.01 PNEUMONIA PNEUMOCOCCAL | 1 0.01 80.02 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 80.03 PNEUMONIA STAPHYLOCOCCAL | 6 0.06 80.09 PNEUMONIA STREPTOCOCCAL | 1 0.01 80.10 PNEUMONIA VIRAL | 3 0.03 80.13 PNEUMONITIS | 1 0.01 80.14 POISONING | 2 0.02 80.16 POLLAKIURIA | 4 0.04 80.20 POLYARTHRITIS | 5 0.05 80.25 POLYMYALGIA | 1 0.01 80.26 POLYMYALGIA RHEUMATICA | 1 0.01 80.27 POLYMYOSITIS | 2 0.02 80.29 POLYURIA | 2 0.02 80.31 POST HERPETIC NEURALGIA | 3 0.03 80.34 POST PROCEDURAL HAEMORRHAGE | 1 0.01 80.35 POST PROCEDURAL NAUSEA | 2 0.02 80.37 POST PROCEDURAL PAIN | 15 0.15 80.52 POST PROCEDURAL VOMITING | 2 0.02 80.54 POST-TRAUMATIC STRESS DISORDER | 7 0.07 80.61 POSTOPERATIVE ANALGESIA | 3 0.03 80.64 POSTOPERATIVE CARE | 2 0.02 80.66 POSTOPERATIVE INFECTION | 2 0.02 80.68 POSTPARTUM DEPRESSION | 1 0.01 80.69 POSTPARTUM HAEMORRHAGE | 3 0.03 80.72 PRADER-WILLI SYNDROME | 1 0.01 80.73 PRE-EXISTING DISEASE | 2 0.02 80.75 PREGNANCY | 1 0.01 80.76 PREGNANCY INDUCED HYPERTENSION | 2 0.02 80.78 PREMATURE BABY | 3 0.03 80.81 PREMATURE LABOUR | 11 0.11 80.92 PREMEDICATION | 56 0.56 81.48 PREMENSTRUAL SYNDROME | 3 0.03 81.51 PREOPERATIVE CARE | 1 0.01 81.52 PROCTITIS HERPES | 1 0.01 81.53 PRODUCTIVE COUGH | 1 0.01 81.54 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 81.55 PROPHYLACTIC CHEMOTHERAPY | 14 0.14 81.69 PROPHYLAXIS | 93 0.93 82.62 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 3 0.03 82.65 PROPHYLAXIS AGAINST HIV INFECTION | 4 0.04 82.69 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 28 0.28 82.97 PROPHYLAXIS OF NAUSEA AND VOMITING | 5 0.05 83.02 PROSTATE CANCER | 43 0.43 83.45 PROSTATE CANCER METASTATIC | 6 0.06 83.51 PROSTATE CANCER STAGE III | 1 0.01 83.52 PROSTATIC ADENOMA | 1 0.01 83.53 PROSTATISM | 1 0.01 83.54 PROSTATITIS | 11 0.11 83.65 PROTEIN C DEFICIENCY | 1 0.01 83.66 PROTEINURIA | 1 0.01 83.67 PRURIGO | 1 0.01 83.68 PRURITUS | 10 0.10 83.78 PSEUDOMONAS INFECTION | 1 0.01 83.79 PSORIASIS | 35 0.35 84.14 PSORIATIC ARTHROPATHY | 7 0.07 84.21 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 84.22 PSYCHOTIC DISORDER | 27 0.27 84.49 PULMONARY CONGESTION | 1 0.01 84.50 PULMONARY EMBOLISM | 3 0.03 84.53 PULMONARY FIBROSIS | 3 0.03 84.56 PULMONARY HYPERTENSION | 32 0.32 84.88 PULMONARY SEPSIS | 1 0.01 84.89 PULMONARY TUBERCULOSIS | 18 0.18 85.07 PURULENT DISCHARGE | 2 0.02 85.09 PYELONEPHRITIS | 1 0.01 85.10 PYODERMA GANGRENOSUM | 1 0.01 85.11 PYREXIA | 17 0.17 85.28 RADICULAR PAIN | 1 0.01 85.29 RADIOFREQUENCY ABLATION | 1 0.01 85.30 RASH | 5 0.05 85.35 RASH ERYTHEMATOUS | 1 0.01 85.36 RASH MACULO-PAPULAR | 2 0.02 85.38 RASH MORBILLIFORM | 2 0.02 85.40 RASH PAPULAR | 1 0.01 85.41 RASH VESICULAR | 1 0.01 85.42 RECTAL CANCER | 4 0.04 85.46 RECTAL CANCER METASTATIC | 1 0.01 85.47 REFLUX OESOPHAGITIS | 3 0.03 85.50 REITER'S SYNDROME | 2 0.02 85.52 RENAL ABSCESS | 4 0.04 85.56 RENAL CANCER METASTATIC | 1 0.01 85.57 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 16 0.16 85.73 RENAL DISORDER | 4 0.04 85.77 RENAL FAILURE | 1 0.01 85.78 RENAL FAILURE CHRONIC | 12 0.12 85.90 RENAL TRANSPLANT | 84 0.84 86.74 RESPIRATORY DISORDER | 7 0.07 86.81 RESPIRATORY MONILIASIS | 1 0.01 86.82 RESPIRATORY TRACT CONGESTION | 1 0.01 86.83 RESPIRATORY TRACT INFECTION | 5 0.05 86.88 RESPIRATORY TRACT INFECTION FUNGAL | 1 0.01 86.89 RESTLESS LEGS SYNDROME | 4 0.04 86.93 RESTLESSNESS | 1 0.01 86.94 RETINAL DETACHMENT | 4 0.04 86.98 RETINAL OEDEMA | 1 0.01 86.99 RHABDOMYOSARCOMA | 11 0.11 87.10 RHEUMATIC HEART DISEASE | 1 0.01 87.11 RHEUMATOID ARTHRITIS | 456 4.56 91.67 RHINITIS | 8 0.08 91.75 RHINITIS ALLERGIC | 5 0.05 91.80 RHINITIS SEASONAL | 1 0.01 91.81 RHINORRHOEA | 4 0.04 91.85 ROSACEA | 1 0.01 91.86 SALIVARY HYPERSECRETION | 2 0.02 91.88 SARCOIDOSIS | 2 0.02 91.90 SARCOMA | 6 0.06 91.96 SARCOMA UTERUS | 3 0.03 91.99 SCAN MYOCARDIAL PERFUSION | 2 0.02 92.01 SCHIZOAFFECTIVE DISORDER | 24 0.24 92.25 SCHIZOPHRENIA | 115 1.15 93.40 SCHIZOPHRENIA, CATATONIC TYPE | 1 0.01 93.41 SCHIZOPHRENIA, DISORGANISED TYPE | 2 0.02 93.43 SCHIZOPHRENIA, PARANOID TYPE | 14 0.14 93.57 SCHIZOTYPAL PERSONALITY DISORDER | 1 0.01 93.58 SCIATICA | 7 0.07 93.65 SCINTIGRAPHY | 1 0.01 93.66 SEASONAL ALLERGY | 4 0.04 93.70 SEBORRHOEIC DERMATITIS | 2 0.02 93.72 SEDATION | 7 0.07 93.79 SELECTIVE IGG SUBCLASS DEFICIENCY | 1 0.01 93.80 SENILE DEMENTIA | 1 0.01 93.81 SEPSIS | 31 0.31 94.12 SEPTIC SHOCK | 1 0.01 94.13 SERRATIA INFECTION | 2 0.02 94.15 SERUM FERRITIN INCREASED | 1 0.01 94.16 SEXUAL DYSFUNCTION | 3 0.03 94.19 SHOCK | 1 0.01 94.20 SICKLE CELL ANAEMIA | 1 0.01 94.21 SINUS CONGESTION | 6 0.06 94.27 SINUS DISORDER | 2 0.02 94.29 SINUS PAIN | 1 0.01 94.30 SINUS TACHYCARDIA | 1 0.01 94.31 SINUSITIS | 29 0.29 94.60 SKELETAL INJURY | 1 0.01 94.61 SKIN DISORDER | 1 0.01 94.62 SKIN INFLAMMATION | 1 0.01 94.63 SKIN LACERATION | 2 0.02 94.65 SKIN PAPILLOMA | 3 0.03 94.68 SKIN WRINKLING | 2 0.02 94.70 SLEEP APNOEA SYNDROME | 1 0.01 94.71 SLEEP DISORDER | 11 0.11 94.82 SLEEP DISORDER THERAPY | 2 0.02 94.84 SMALL CELL CARCINOMA | 1 0.01 94.85 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 2 0.02 94.87 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 25 0.25 95.12 SMOKER | 1 0.01 95.13 SMOKING CESSATION THERAPY | 6 0.06 95.19 SOCIAL PHOBIA | 6 0.06 95.25 SOMNOLENCE | 6 0.06 95.31 SPINAL ANAESTHESIA | 3 0.03 95.34 SPINAL COLUMN STENOSIS | 3 0.03 95.37 SPINAL DISORDER | 1 0.01 95.38 SPINAL FRACTURE | 2 0.02 95.40 SPINAL MYELOGRAM | 1 0.01 95.41 SPINAL OSTEOARTHRITIS | 2 0.02 95.43 SPONDYLOLISTHESIS ACQUIRED | 1 0.01 95.44 SPONDYLOSIS | 1 0.01 95.45 SPUTUM CULTURE POSITIVE | 1 0.01 95.46 SQUAMOUS CELL CARCINOMA | 14 0.14 95.60 SQUAMOUS CELL CARCINOMA OF THE CERVIX | 1 0.01 95.61 STAPHYLOCOCCAL ABSCESS | 1 0.01 95.62 STAPHYLOCOCCAL INFECTION | 11 0.11 95.73 STAPHYLOCOCCAL SEPSIS | 1 0.01 95.74 STATUS EPILEPTICUS | 1 0.01 95.75 STEM CELL TRANSPLANT | 17 0.17 95.92 STENOTROPHOMONAS INFECTION | 1 0.01 95.93 STENT PLACEMENT | 5 0.05 95.98 STERNAL FRACTURE | 1 0.01 95.99 STEROID THERAPY | 1 0.01 96.00 STOMACH DISCOMFORT | 4 0.04 96.04 STRABISMUS | 1 0.01 96.05 STREPTOCOCCAL INFECTION | 1 0.01 96.06 STREPTOCOCCAL SEPSIS | 1 0.01 96.07 STRESS INCONTINENCE | 1 0.01 96.08 STRESS SYMPTOMS | 1 0.01 96.09 STUPOR | 1 0.01 96.10 STURGE-WEBER SYNDROME | 1 0.01 96.11 SUBDIAPHRAGMATIC ABSCESS | 4 0.04 96.15 SUICIDE ATTEMPT | 6 0.06 96.21 SUPERINFECTION | 1 0.01 96.22 SUPERINFECTION LUNG | 4 0.04 96.26 SUPPRESSED LACTATION | 3 0.03 96.29 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 96.30 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.31 SURGERY | 22 0.22 96.53 SWELLING | 1 0.01 96.54 SYNCOPE | 1 0.01 96.55 SYSTEMIC ANTIFUNGAL TREATMENT | 9 0.09 96.64 SYSTEMIC CANDIDA | 1 0.01 96.65 SYSTEMIC LUPUS ERYTHEMATOSUS | 1 0.01 96.66 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 96.67 SYSTEMIC MASTOCYTOSIS | 1 0.01 96.68 SYSTEMIC MYCOSIS | 3 0.03 96.71 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA | 3 0.03 96.74 T-CELL LYMPHOMA | 5 0.05 96.79 TACHYCARDIA | 4 0.04 96.83 TARDIVE DYSKINESIA | 4 0.04 96.87 TEMPORAL ARTERITIS | 1 0.01 96.88 TEMPORAL LOBE EPILEPSY | 1 0.01 96.89 TENDONITIS | 5 0.05 96.94 TENSION HEADACHE | 1 0.01 96.95 TESTIS CANCER | 13 0.13 97.08 THINKING ABNORMAL | 2 0.02 97.10 THROAT IRRITATION | 1 0.01 97.11 THROMBASTHENIA | 1 0.01 97.12 THROMBOCYTOPENIA | 2 0.02 97.14 THROMBOCYTOPENIC PURPURA | 1 0.01 97.15 THROMBOPHLEBITIS | 7 0.07 97.22 THROMBOSIS | 13 0.13 97.35 THROMBOSIS PROPHYLAXIS | 25 0.25 97.60 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 97.62 THYMOMA MALIGNANT | 1 0.01 97.63 THYROID DISORDER | 1 0.01 97.64 THYROID STIMULATING HORMONE-PRODUCING.. | 1 0.01 97.65 THYROIDECTOMY | 2 0.02 97.67 THYROIDECTOMY PARTIAL | 1 0.01 97.68 THYROXINE DECREASED | 1 0.01 97.69 THYROXINE THERAPY | 2 0.02 97.71 TINNITUS | 1 0.01 97.72 TOBACCO ABUSE | 2 0.02 97.74 TONSILLITIS | 2 0.02 97.76 TOOTH ABSCESS | 2 0.02 97.78 TOOTH DISORDER | 1 0.01 97.79 TOOTH EXTRACTION | 1 0.01 97.80 TOOTH INFECTION | 2 0.02 97.82 TOOTHACHE | 6 0.06 97.88 TORTICOLLIS | 6 0.06 97.94 TOURETTE'S DISORDER | 1 0.01 97.95 TOXIC SKIN ERUPTION | 1 0.01 97.96 TOXOPLASMOSIS | 1 0.01 97.97 TRACHEOBRONCHITIS | 5 0.05 98.02 TRANS-SEXUALISM | 1 0.01 98.03 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 98.06 TRANSITIONAL CELL CARCINOMA | 1 0.01 98.07 TRANSPLANT | 2 0.02 98.09 TREMOR | 2 0.02 98.11 TRIGEMINAL NEURALGIA | 3 0.03 98.14 TUBERCULIN TEST | 2 0.02 98.16 TUBERCULIN TEST POSITIVE | 1 0.01 98.17 TUBERCULOSIS | 24 0.24 98.41 TURNER'S SYNDROME | 1 0.01 98.42 ULCER | 1 0.01 98.43 UNEVALUABLE EVENT | 3 0.03 98.46 UNWANTED PREGNANCY | 1 0.01 98.47 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 98.49 UPPER LIMB FRACTURE | 1 0.01 98.50 UPPER RESPIRATORY TRACT INFECTION | 11 0.11 98.61 UPPER RESPIRATORY TRACT INFLAMMATION | 4 0.04 98.65 URINARY INCONTINENCE | 5 0.05 98.70 URINARY TRACT INFECTION | 40 0.40 99.10 UROGRAPHY | 1 0.01 99.11 UROSEPSIS | 2 0.02 99.13 URTICARIA | 2 0.02 99.15 UTERINE CANCER | 7 0.07 99.22 UTERINE HAEMORRHAGE | 1 0.01 99.23 UTERINE LEIOMYOMA | 1 0.01 99.24 UTERINE LEIOMYOSARCOMA | 6 0.06 99.30 UVEITIS | 5 0.05 99.35 VAGINAL INFECTION | 1 0.01 99.36 VAGINAL MYCOSIS | 1 0.01 99.37 VARICELLA | 1 0.01 99.38 VARICOSE ULCERATION | 1 0.01 99.39 VASCULAR DEMENTIA | 2 0.02 99.41 VASCULAR OPERATION | 2 0.02 99.43 VASCULITIS | 3 0.03 99.46 VASOCONSTRICTION | 1 0.01 99.47 VENOUS INSUFFICIENCY | 4 0.04 99.51 VENTRICULAR ARRHYTHMIA | 1 0.01 99.52 VENTRICULAR EXTRASYSTOLES | 4 0.04 99.56 VENTRICULAR HYPERTROPHY | 2 0.02 99.58 VENTRICULAR TACHYCARDIA | 5 0.05 99.63 VERTIGO | 2 0.02 99.65 VIRAL INFECTION | 1 0.01 99.66 VIRAL PERICARDITIS | 1 0.01 99.67 VITAMIN D DEFICIENCY | 1 0.01 99.68 VITAMIN SUPPLEMENTATION | 4 0.04 99.72 VOMITING | 12 0.12 99.84 VON WILLEBRAND'S DISEASE | 1 0.01 99.85 VULVOVAGINAL DRYNESS | 1 0.01 99.86 WALDENSTROM'S MACROGLOBULINAEMIA | 6 0.06 99.92 WEGENER'S GRANULOMATOSIS | 1 0.01 99.93 WEIGHT CONTROL | 2 0.02 99.95 WEIGHT DECREASED | 3 0.03 99.98 WISDOM TEETH REMOVAL | 1 0.01 99.99 XANTHOGRANULOMA | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015